Pegylated Interferon-α2a and Ribavirin versus Pegylated Interferon-α2b and Ribavirin in Chronic Hepatitis CA Meta-Analysis

被引：0
|
作者：
Nicolas Flori
Natalie Funakoshi
Yohan Duny
Jean-Christophe Valats
Michael Bismuth
Dimitri Christophorou
Jean-Pierre Daurès
Pierre Blanc
机构：
[1] Hôpital Saint Eloi,Service d’Hépato
[2] CHU Nîmes,gastroentérologie B
来源：
Drugs | 2013年 / 73卷
关键词：
Chronic Hepatitis; Publication Bias; Sustained Virological Response; Telaprevir; Boceprevir;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：263 / 277
页数：14
相关论文
共 50 条
  • [1] Pegylated Interferon-α2a and Ribavirin versus Pegylated Interferon-α2b and Ribavirin in Chronic Hepatitis C A Meta-Analysis
    Flori, Nicolas
    Funakoshi, Natalie
    Duny, Yohan
    Valats, Jean-Christophe
    Bismuth, Michael
    Christophorou, Dimitri
    Daures, Jean-Pierre
    Blanc, Pierre
    DRUGS, 2013, 73 (03) : 263 - 277
  • [2] Efficacy and Tolerability of Pegylated Interferon-α2a plus Ribavirin versus Pegylated Interferon-α2b plus Ribavirin in Treatment-Naive Chronic Hepatitis C Patients
    Lee, Seok
    Kim, In Hee
    Kim, Seong Hun
    Kim, Sang Wook
    Lee, Seung Ok
    Lee, Soo Teik
    Kim, Dae Ghon
    Lee, Chang Seop
    Choi, Chang Soo
    Cho, Eun Young
    Kim, Haak Cheoul
    INTERVIROLOGY, 2010, 53 (03) : 146 - 153
  • [3] Differential Antiviral Effects of Pegylated Interferon-α2a and Pegylated Interferon-α2b in Chronic Hepatitis C
    Durante-Mangoni, Emanuele
    Parrella, Antonio
    Iossa, Domenico
    Andini, Roberto
    Molaro, Rosa
    Battimelli, Carminia
    Sodano, Giuseppe
    Utili, Riccardo
    CLINICAL DRUG INVESTIGATION, 2014, 34 (12) : 871 - 878
  • [4] Differential Antiviral Effects of Pegylated Interferon-α2a and Pegylated Interferon-α2b in Chronic Hepatitis C
    Emanuele Durante-Mangoni
    Antonio Parrella
    Domenico Iossa
    Roberto Andini
    Rosa Molaro
    Carminia Battimelli
    Giuseppe Sodano
    Riccardo Utili
    Clinical Drug Investigation, 2014, 34 : 871 - 878
  • [5] Catatonia Associated with Pegylated Interferon-α 2b and Ribavirin for Hepatitis C
    Quinn, Davin
    Kuchler, Elizabeth
    Deming, Paulina
    Arora, Sanjeev
    PSYCHOSOMATICS, 2012, 53 (04) : 400 - 401
  • [6] Pegylated interferon-α2a versus pegylated interferon-α2b in hepatitis C: reappraisal of effectiveness on the basis of trial sequential analysis
    Messori, Andrea
    Fadda, Valeria
    Maratea, Dario
    Trippoli, Sabrina
    Marinai, Claudio
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 26 (02) : 246 - 248
  • [7] Pegylated interferon α2a plus ribavirin versus pegylated interferon α2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients
    Berenguer, J.
    Gonzalez-Garcia, J.
    Lopez-Aldeguer, J.
    Von-Wichmann, M. A.
    Quereda, C.
    Hernando, A.
    Sanz, J.
    Tural, C.
    Ortega, E.
    Mallolas, J.
    Santos, I.
    Miralles, P.
    Montes, M. L.
    Bellon, J. M.
    Esteban, H.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (06) : 1256 - 1263
  • [8] A randomized prospective clinical trial comparing pegylated interferon alpha 2a/ribavirin versus pegylated interferon alpha 2b/ribavirin in the treatment of Chronic Hepatitis C
    Sinha, S
    Gulur, P
    Patel, V
    Hage-Nassar, G
    Tenner, S
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S77 - S78
  • [9] Interferon-α-2b/pegylated interferon and ribavirin treatment in renal disease with renal insufficiency and chronic hepatitis C infection
    Bruchfeld, A
    Lindahl, K
    Schvarcz, R
    Ståhle, L
    ANTIVIRAL THERAPY, 2002, 7 (04) : L127 - L127
  • [10] Pioglitazone in chronic hepatitis C not responding to pegylated interferon-α and ribavirin
    Overbeck, Kathrin
    Genne, Daniel
    Golay, Alain
    Negro, Francesco
    JOURNAL OF HEPATOLOGY, 2008, 49 (02) : 295 - 298
12345